Final guidance from NICE on Merck, Pfizer’s Bavencio
admin 12th April 2018 Uncategorised 0The National Institute for Health and Care Excellence has now published final guidelines endorsing Merck and Pfizer’s Bavencio as an option for patients with Merkel cell carcinoma (MCC).
More: Final guidance from NICE on Merck, Pfizer’s Bavencio
Source: News